Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis

Flavien Vincent, MD, PhD; Julien Ternacle, MD, PhD*; Tom Denimal, MD; Mylène Shen, MSc; Bjorn Redfors, MD, PhD; Cédric Delhaye, MD; Matheus Simonato, MD; Nicolas Debry, MD; Basile Verdier, MD; Bahira Shahim, MD, PhD; Thibault Pamart, MD; Hugues Spillemaeker, MD; Guillaume Schurtz, MD; François Pontana, MD, PhD; Vinod H. Thourani, MD; Philippe Pibarot, DVM, PhD; Eric Van Belle, MD, PhD


Circulation. 2021;143(10):1043-1061. 

In This Article

BAV Burden in Patients Referred for TAVR

BAV is the most frequent congenital heart disease, occurring in 1% to 2% of the population,[11] and represents half of the patients referred for AVR. Before the TAVR era, BAV patients 80 years of age or older represented 22% to 28% of the patients referred for SAVR.[12,13] In this elderly population, the utilization of a less invasive therapy is frequently preferred and approximately 10% of patients currently treated by TAVR have a BAV.[14] Thus, a substantial number of patients are referred for TAVR in contemporary practice.